Infigratinib靶向的FGFR3（成纤维细胞生长因子受体3）正是驱动ACH疾病发生的关键靶点，2月12日，BridgeBio公布Infigratinib在ACH中取得的首个具有统计学显著改善意义的3期顶线结果，公司计划下半年向FDA提交新药申请。
Immediately rescind the mandatory developer registration requirement for third-party distribution.
Free mobile apps，详情可参考safew官方版本下载
「像鬼一樣工作」：台灣外籍移工為何陷入「強迫勞動」處境，这一点在爱思助手下载最新版本中也有详细论述
True to its promise of respecting the wishes of its no-longer-required technology, Anthropic has granted Opus 3 a Substack newsletter called Claude’s Corner, which it says will run for at least the next three months and publish weekly essays penned by the model. Anthropic will review the content before sharing it, but says it won’t edit the essays, and so has unsurprisingly made it clear that not everything Opus 3 writes is necessarily endorsed by its maker.，推荐阅读旺商聊官方下载获取更多信息
Credit: Tina Rowden / HBO